Skip to main content
Top
Published in: BMC Oral Health 1/2020

01-12-2020 | Cannabinoid | Research article

Methanandamide diminish the Porphyromonas gingivalis lipopolysaccharide induced response in human periodontal ligament cells

Authors: Fengqiu Zhang, Burcu Özdemir, Phuong Quynh Nguyen, Oleh Andrukhov, Xiaohui Rausch-Fan

Published in: BMC Oral Health | Issue 1/2020

Login to get access

Abstract

Background

The endocannabinoid system is involved in the regulation of periodontal tissue homeostasis. Synthetic cannabinoid methanandamide (Meth-AEA) has improved stability and affinity to cannabinoid receptors compared to its endogenous analog anandamide. In the present study, we investigated the effect of methanandamide on the production of pro-inflammatory mediators in primary human periodontal ligament cells (hPdLCs).

Methods

hPdLCs were treated with Meth-AEA for 24 h, and the resulting production of interleukin (IL)-6, IL-8, and monocyte chemotactic protein (MCP)-1 was measured in the absence or the presence of Porphyromonas gingivalis lipopolysaccharide (LPS). Additionally, the effect of Meth-AEA on the proliferation/viability of hPdLCs was measured by the MTT method.

Results

Methanandamide at a concentration of 10 μM significantly inhibited P. gingivalis LPS induced production of IL-6, IL-8, and MCP-1. Basal production of IL-6 and IL-8 was slightly enhanced by 10 μM Meth-AEA. No effect of Meth-AEA on the basal production of MCP-1 was observed. Meth-AEA in concentrations up to 10 μM did not affect the proliferation/viability of hPdLCs, but significantly inhibited it at a concentration of 30 μM.

Conclusion

Our study suggests that the inflammatory response in periodontal ligament cells could be influenced by the activation of the cannabinoid system, which might be potentially involved in the progression of periodontal disease.
Literature
1.
go back to reference Kinane DF, Attstrom R. Advances in the pathogenesis of periodontitis. Group B consensus report of the fifth European Workshop in Periodontology. J Clin Periodontol. 2005;32(Suppl 6):130–1.PubMedCrossRef Kinane DF, Attstrom R. Advances in the pathogenesis of periodontitis. Group B consensus report of the fifth European Workshop in Periodontology. J Clin Periodontol. 2005;32(Suppl 6):130–1.PubMedCrossRef
2.
3.
go back to reference Socransky SS. Haffajee AD (2005) Periodontal microbial ecology. Periodontol. 2000;38:135–87.CrossRef Socransky SS. Haffajee AD (2005) Periodontal microbial ecology. Periodontol. 2000;38:135–87.CrossRef
5.
go back to reference Holt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000. 1999;20:168–238.PubMedCrossRef Holt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000. 1999;20:168–238.PubMedCrossRef
6.
go back to reference Bainbridge BW, Coats SR, Darveau RP. Porphyromonas gingivalis lipopolysaccharide displays functionally diverse interactions with the innate host defense system. Ann Periodontol. 2002;7:29–37.PubMedCrossRef Bainbridge BW, Coats SR, Darveau RP. Porphyromonas gingivalis lipopolysaccharide displays functionally diverse interactions with the innate host defense system. Ann Periodontol. 2002;7:29–37.PubMedCrossRef
9.
go back to reference Bab I, Ofek O, Tam J, Rehnelt J, Zimmer A. Endocannabinoids and the regulation of bone metabolism. J Neuroendocrinol. 2008;20(Suppl 1):69–74.PubMedCrossRef Bab I, Ofek O, Tam J, Rehnelt J, Zimmer A. Endocannabinoids and the regulation of bone metabolism. J Neuroendocrinol. 2008;20(Suppl 1):69–74.PubMedCrossRef
10.
go back to reference Opitz CA, Rimmerman N, Zhang Y, Mead LE, Yoder MC, et al. Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells. FEBS Lett. 2007;581:4927–31.PubMedPubMedCentralCrossRef Opitz CA, Rimmerman N, Zhang Y, Mead LE, Yoder MC, et al. Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells. FEBS Lett. 2007;581:4927–31.PubMedPubMedCentralCrossRef
11.
go back to reference Konermann A, Jager A, Held SA, Brossart P, Schmole A. In vivo and in vitro identification of Endocannabinoid signaling in periodontal tissues and their potential role in local pathophysiology. Cell Mol Neurobiol. 2017. Konermann A, Jager A, Held SA, Brossart P, Schmole A. In vivo and in vitro identification of Endocannabinoid signaling in periodontal tissues and their potential role in local pathophysiology. Cell Mol Neurobiol. 2017.
12.
13.
go back to reference Cabral GA, Rogers TJ, Lichtman AH. Turning over a new leaf: cannabinoid and Endocannabinoid modulation of immune function. J NeuroImmune Pharmacol. 2015;10:193–203.PubMedPubMedCentralCrossRef Cabral GA, Rogers TJ, Lichtman AH. Turning over a new leaf: cannabinoid and Endocannabinoid modulation of immune function. J NeuroImmune Pharmacol. 2015;10:193–203.PubMedPubMedCentralCrossRef
14.
go back to reference Nakajima Y, Furuichi Y, Biswas KK, Hashiguchi T, Kawahara K, et al. Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. FEBS Lett. 2006;580:613–9.PubMedCrossRef Nakajima Y, Furuichi Y, Biswas KK, Hashiguchi T, Kawahara K, et al. Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. FEBS Lett. 2006;580:613–9.PubMedCrossRef
15.
go back to reference Kozono S, Matsuyama T, Biwasa KK, Kawahara K, Nakajima Y, et al. Involvement of the endocannabinoid system in periodontal healing. Biochem Biophys Res Commun. 2010;394:928–33.PubMedCrossRef Kozono S, Matsuyama T, Biwasa KK, Kawahara K, Nakajima Y, et al. Involvement of the endocannabinoid system in periodontal healing. Biochem Biophys Res Commun. 2010;394:928–33.PubMedCrossRef
16.
go back to reference Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11:72–80. Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11:72–80.
17.
go back to reference Lanza Cariccio V, Scionti D, Raffa A, Iori R, Pollastro F, et al. Treatment of periodontal ligament stem cells with MOR and CBD promotes cell survival and neuronal differentiation via the PI3K/Akt/mTOR pathway. Int J Mol Sci. 2018;19. Lanza Cariccio V, Scionti D, Raffa A, Iori R, Pollastro F, et al. Treatment of periodontal ligament stem cells with MOR and CBD promotes cell survival and neuronal differentiation via the PI3K/Akt/mTOR pathway. Int J Mol Sci. 2018;19.
18.
go back to reference Ozdemir B, Shi B, Bantleon HP, Moritz A, Rausch-Fan X, et al. Endocannabinoids and inflammatory response in periodontal ligament cells. PLoS One. 2014;9:e107407.PubMedPubMedCentralCrossRef Ozdemir B, Shi B, Bantleon HP, Moritz A, Rausch-Fan X, et al. Endocannabinoids and inflammatory response in periodontal ligament cells. PLoS One. 2014;9:e107407.PubMedPubMedCentralCrossRef
19.
go back to reference Rettori E, De Laurentiis A, Zorrilla Zubilete M, Rettori V, Elverdin JC. Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat. Neuroimmunomodulation. 2012;19:293–303.PubMedCrossRef Rettori E, De Laurentiis A, Zorrilla Zubilete M, Rettori V, Elverdin JC. Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat. Neuroimmunomodulation. 2012;19:293–303.PubMedCrossRef
20.
go back to reference Yan W, Cao Y, Yang H, Han N, Zhu X, et al. CB1 enhanced the osteo/dentinogenic differentiation ability of periodontal ligament stem cells via p38 MAPK and JNK in an inflammatory environment. Cell Prolif. 2019;52:e12691.PubMedPubMedCentralCrossRef Yan W, Cao Y, Yang H, Han N, Zhu X, et al. CB1 enhanced the osteo/dentinogenic differentiation ability of periodontal ligament stem cells via p38 MAPK and JNK in an inflammatory environment. Cell Prolif. 2019;52:e12691.PubMedPubMedCentralCrossRef
21.
go back to reference Jarho P, Urtti A, Jarvinen K, Pate DW, Jarvinen T (1996) Hydroxypropyl-beta-cyclodextrin increases aqueous solubility and stability of anandamide. Life Sci 58: PL 181-185. Jarho P, Urtti A, Jarvinen K, Pate DW, Jarvinen T (1996) Hydroxypropyl-beta-cyclodextrin increases aqueous solubility and stability of anandamide. Life Sci 58: PL 181-185.
22.
go back to reference Palmer SL, Khanolkar AD, Makriyannis A. Natural and synthetic endocannabinoids and their structure-activity relationships. Curr Pharm Des. 2000;6:1381–97.PubMedCrossRef Palmer SL, Khanolkar AD, Makriyannis A. Natural and synthetic endocannabinoids and their structure-activity relationships. Curr Pharm Des. 2000;6:1381–97.PubMedCrossRef
23.
go back to reference Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, et al. (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem. 1994;37:1889–93.PubMedCrossRef Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, et al. (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem. 1994;37:1889–93.PubMedCrossRef
24.
go back to reference Goutopoulos A, Fan P, Khanolkar AD, Xie XQ, Lin S, et al. Stereochemical selectivity of methanandamides for the CB1 and CB2 cannabinoid receptors and their metabolic stability. Bioorg Med Chem. 2001;9:1673–84.PubMedCrossRef Goutopoulos A, Fan P, Khanolkar AD, Xie XQ, Lin S, et al. Stereochemical selectivity of methanandamides for the CB1 and CB2 cannabinoid receptors and their metabolic stability. Bioorg Med Chem. 2001;9:1673–84.PubMedCrossRef
25.
go back to reference Ossola CA, Surkin PN, Pugnaloni A, Mohn CE, Elverdin JC, et al. Long-term treatment with methanandamide attenuates LPS-induced periodontitis in rats. Inflamm Res. 2012;61:941–8.PubMedCrossRef Ossola CA, Surkin PN, Pugnaloni A, Mohn CE, Elverdin JC, et al. Long-term treatment with methanandamide attenuates LPS-induced periodontitis in rats. Inflamm Res. 2012;61:941–8.PubMedCrossRef
26.
go back to reference Behm C, Blufstein A, Gahn J, Noroozkhan N, Moritz A, et al. Soluble CD14 enhances the response of periodontal ligament stem cells to toll-like receptor 2 agonists. Mediat Inflamm. 2019;2019:8127301.CrossRef Behm C, Blufstein A, Gahn J, Noroozkhan N, Moritz A, et al. Soluble CD14 enhances the response of periodontal ligament stem cells to toll-like receptor 2 agonists. Mediat Inflamm. 2019;2019:8127301.CrossRef
27.
go back to reference Blufstein A, Behm C, Gahn J, Uitz O, Naumovska I, et al. Synergistic effects triggered by simultaneous toll-like receptor-2 and -3 activation in human periodontal ligament stem cells. J Periodontol. 2019;90:1190–201.PubMedPubMedCentralCrossRef Blufstein A, Behm C, Gahn J, Uitz O, Naumovska I, et al. Synergistic effects triggered by simultaneous toll-like receptor-2 and -3 activation in human periodontal ligament stem cells. J Periodontol. 2019;90:1190–201.PubMedPubMedCentralCrossRef
28.
go back to reference Andrukhov O, Andrukhova O, Ozdemir B, Haririan H, Muller-Kern M, et al. Soluble CD14 enhances the response of periodontal ligament stem cells to P. gingivalis lipopolysaccharide. PLoS One. 2016;11:e0160848.PubMedPubMedCentralCrossRef Andrukhov O, Andrukhova O, Ozdemir B, Haririan H, Muller-Kern M, et al. Soluble CD14 enhances the response of periodontal ligament stem cells to P. gingivalis lipopolysaccharide. PLoS One. 2016;11:e0160848.PubMedPubMedCentralCrossRef
29.
go back to reference Andrukhov O, Hong JS, Andrukhova O, Blufstein A, Moritz A, et al. Response of human periodontal ligament stem cells to IFN-gamma and TLR-agonists. Sci Rep. 2017;7:12856.PubMedPubMedCentralCrossRef Andrukhov O, Hong JS, Andrukhova O, Blufstein A, Moritz A, et al. Response of human periodontal ligament stem cells to IFN-gamma and TLR-agonists. Sci Rep. 2017;7:12856.PubMedPubMedCentralCrossRef
31.
go back to reference Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25:402–8.PubMedCrossRef Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25:402–8.PubMedCrossRef
32.
go back to reference Andrukhov O, Behm C, Blufstein A, Rausch-Fan X. Immunomodulatory properties of dental tissue-derived mesenchymal stem cells: implication in disease and tissue regeneration. World J Stem Cells. 2019;11(9):604–17.PubMedPubMedCentralCrossRef Andrukhov O, Behm C, Blufstein A, Rausch-Fan X. Immunomodulatory properties of dental tissue-derived mesenchymal stem cells: implication in disease and tissue regeneration. World J Stem Cells. 2019;11(9):604–17.PubMedPubMedCentralCrossRef
33.
go back to reference Behm C, Blufstein A, Gahn J, Kubin B, Nemec M, et al. 1,25(OH)2D3 differently affects Immunomodulatory activities of Mesenchymal stem cells depending on the presence of TNF-alpha, IL-1beta and IFN-gamma. J Clin Med. 2019;8. Behm C, Blufstein A, Gahn J, Kubin B, Nemec M, et al. 1,25(OH)2D3 differently affects Immunomodulatory activities of Mesenchymal stem cells depending on the presence of TNF-alpha, IL-1beta and IFN-gamma. J Clin Med. 2019;8.
34.
go back to reference Nibali L, Fedele S, D'Aiuto F, Donos N. Interleukin-6 in oral diseases: a review. Oral Dis. 2012;18:236–43.PubMedCrossRef Nibali L, Fedele S, D'Aiuto F, Donos N. Interleukin-6 in oral diseases: a review. Oral Dis. 2012;18:236–43.PubMedCrossRef
35.
go back to reference Kurtis B, Tuter G, Serdar M, Akdemir P, Uygur C, et al. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol. 2005;76:1849–55.PubMedCrossRef Kurtis B, Tuter G, Serdar M, Akdemir P, Uygur C, et al. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol. 2005;76:1849–55.PubMedCrossRef
36.
go back to reference Finoti LS, Nepomuceno R, Pigossi SC, Corbi SC, Secolin R, et al. Association between interleukin-8 levels and chronic periodontal disease: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2017;96:e6932.CrossRef Finoti LS, Nepomuceno R, Pigossi SC, Corbi SC, Secolin R, et al. Association between interleukin-8 levels and chronic periodontal disease: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2017;96:e6932.CrossRef
37.
go back to reference Blufstein A, Behm C, Nguyen PQ, Rausch-Fan X, Andrukhov O. Human periodontal ligament cells exhibit no endotoxin tolerance upon stimulation with Porphyromonas gingivalis lipopolysaccharide. J Periodontal Res. 2018. Blufstein A, Behm C, Nguyen PQ, Rausch-Fan X, Andrukhov O. Human periodontal ligament cells exhibit no endotoxin tolerance upon stimulation with Porphyromonas gingivalis lipopolysaccharide. J Periodontal Res. 2018.
38.
go back to reference Albiero ML, Amorim BR, Martins L, Casati MZ, Sallum EA, et al. Exposure of periodontal ligament progenitor cells to lipopolysaccharide from Escherichia coli changes osteoblast differentiation pattern. J Appl Oral Sci. 2015;23:145–52.PubMedPubMedCentralCrossRef Albiero ML, Amorim BR, Martins L, Casati MZ, Sallum EA, et al. Exposure of periodontal ligament progenitor cells to lipopolysaccharide from Escherichia coli changes osteoblast differentiation pattern. J Appl Oral Sci. 2015;23:145–52.PubMedPubMedCentralCrossRef
39.
go back to reference Olea-Herrero N, Vara D, Malagarie-Cazenave S, Diaz-Laviada I. The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells. J Immunotoxicol. 2009;6:249–56.PubMedCrossRef Olea-Herrero N, Vara D, Malagarie-Cazenave S, Diaz-Laviada I. The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells. J Immunotoxicol. 2009;6:249–56.PubMedCrossRef
40.
go back to reference Ossola CA, Surkin PN, Mohn CE, Elverdin JC, Fernandez-Solari J. Anti-inflammatory and Osteoprotective effects of Cannabinoid-2 receptor agonist HU-308 in a rat model of lipopolysaccharide-induced periodontitis. J Periodontol. 2016;87:725–34.PubMedCrossRef Ossola CA, Surkin PN, Mohn CE, Elverdin JC, Fernandez-Solari J. Anti-inflammatory and Osteoprotective effects of Cannabinoid-2 receptor agonist HU-308 in a rat model of lipopolysaccharide-induced periodontitis. J Periodontol. 2016;87:725–34.PubMedCrossRef
41.
go back to reference Abidi AH, Presley CS, Dabbous M, Tipton DA, Mustafa SM, et al. Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts. Arch Oral Biol. 2018;87:79–85.PubMedCrossRef Abidi AH, Presley CS, Dabbous M, Tipton DA, Mustafa SM, et al. Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts. Arch Oral Biol. 2018;87:79–85.PubMedCrossRef
42.
go back to reference Baskfield CY, Martin BR, Wiley JL. Differential effects of delta9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice. J Pharmacol Exp Ther. 2004;309:86–91.PubMedCrossRef Baskfield CY, Martin BR, Wiley JL. Differential effects of delta9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice. J Pharmacol Exp Ther. 2004;309:86–91.PubMedCrossRef
43.
44.
go back to reference Roberts LA, Ross HR, Connor M. Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro. Neuropharmacology. 2008;54:172–80.PubMedCrossRef Roberts LA, Ross HR, Connor M. Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro. Neuropharmacology. 2008;54:172–80.PubMedCrossRef
45.
go back to reference Christopoulos A, Wilson K. Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors. Brain Res. 2001;915:70–8.PubMedCrossRef Christopoulos A, Wilson K. Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors. Brain Res. 2001;915:70–8.PubMedCrossRef
46.
go back to reference Warren KR, Postolache TT, Groer ME, Pinjari O, Kelly DL, et al. Role of chronic stress and depression in periodontal diseases. Periodontol. 2014;2000(64):127–38.CrossRef Warren KR, Postolache TT, Groer ME, Pinjari O, Kelly DL, et al. Role of chronic stress and depression in periodontal diseases. Periodontol. 2014;2000(64):127–38.CrossRef
47.
go back to reference Haririan H, Andrukhov O, Bottcher M, Pablik E, Wimmer G, et al. Salivary neuropeptides, Stress and Periodontitis. J Periodontol. 2017:1–15. Haririan H, Andrukhov O, Bottcher M, Pablik E, Wimmer G, et al. Salivary neuropeptides, Stress and Periodontitis. J Periodontol. 2017:1–15.
49.
go back to reference Rettori E, De Laurentiis A, Dees WL, Endruhn A, Rettori V. Host neuro- immuno-endocrine responses in periodontal disease. Curr Pharm Des. 2014;20:4749–59.PubMedCrossRef Rettori E, De Laurentiis A, Dees WL, Endruhn A, Rettori V. Host neuro- immuno-endocrine responses in periodontal disease. Curr Pharm Des. 2014;20:4749–59.PubMedCrossRef
50.
go back to reference Shields GS, Kuchenbecker SY, Pressman SD, Sumida KD, Slavich GM. Better cognitive control of emotional information is associated with reduced pro-inflammatory cytokine reactivity to emotional stress. Stress. 2016;19:63–8.PubMedPubMedCentralCrossRef Shields GS, Kuchenbecker SY, Pressman SD, Sumida KD, Slavich GM. Better cognitive control of emotional information is associated with reduced pro-inflammatory cytokine reactivity to emotional stress. Stress. 2016;19:63–8.PubMedPubMedCentralCrossRef
51.
go back to reference Morena M, Patel S, Bains JS, Hill MN. Neurobiological interactions between stress and the Endocannabinoid system. Neuropsychopharmacology. 2016;41:80–102.PubMedCrossRef Morena M, Patel S, Bains JS, Hill MN. Neurobiological interactions between stress and the Endocannabinoid system. Neuropsychopharmacology. 2016;41:80–102.PubMedCrossRef
Metadata
Title
Methanandamide diminish the Porphyromonas gingivalis lipopolysaccharide induced response in human periodontal ligament cells
Authors
Fengqiu Zhang
Burcu Özdemir
Phuong Quynh Nguyen
Oleh Andrukhov
Xiaohui Rausch-Fan
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2020
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-020-01087-6

Other articles of this Issue 1/2020

BMC Oral Health 1/2020 Go to the issue